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ABSTRACT
For several years the percutaneous closure of patent ductus 
arteriosus has been a reliable and effective technique for most 
of the morphologic variants described by Krichenko. Type B, 
or window-type, patent ductus arteriosus remains a challenge 
due to the higher risk of device embolizations and incomplete 
occlusions. We report the successful use of AMPLATZER™ 
septal occluder in three patients with window-type patent 
ductus arteriosus, two cases treated with a 5-mm device and 
one case with a 7-mm device. The AMPLATZER™ device 
designed for the occlusion of atrial septal defects is effective 
for the percutaneous treatment of this morphological variant 
of patent ductus arteriosus.
DESCRIPTORS: Ductus arteriosus, patent. Cardiac catheteri-
zation. Blood vessel prosthesis implantation.
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RESUMO
Fechamento do Canal Arterial Persistente Tipo Janela 
Com o Oclusor Septal AMPLATZER™
Há vários anos, a oclusão percutânea do canal arterial persis-
tente é uma técnica factível e eficaz na maioria das variantes 
morfológicas descritas por Krishenko. O tipo B, em janela, 
caracterizado por ser curto, permanece um desafio, devido 
ao maior risco de embolizações das próteses e das oclusões 
incompletas. Descrevemos aqui o uso bem-sucedido de oclusores 
septais AMPLATZER™ em três pacientes com canal arterial 
em janela, dois casos tratados com dispositivos de 5 mm e 
um com o de 7 mm. O dispositivo AMPLATZER™ desenhado 
para a oclusão da comunicação interatrial mostrou-se eficaz 
para o tratamento percutâneo dessa variante morfológica de 
canal arterial persistente.
DESCRITORES: Permeabilidade do canal arterial. Cateterismo 
cardíaco. Implante de prótese vascular.
P ercutaneous exclusion of patent ductus arteriosus (PDA) is a feasible and effective technique in most morphological variants described by Krichenko et 
al.1 However, type B or window-type PDA, characterized 
as short, remains a challenge due to the higher risk 
of prosthesis embolization and incomplete occlusions. 
To solve this limitation in adults, double disk devices 
originally designed for the occlusion of septal defects 
have been used, such as CardioSEAL®, Starflex® and, 
more recently, AMPLATZER™.2-6
This is a report of three cases with window-type 
PDA treated with AMPLATZER™ Septal Occluder (AGA 
Medical Corp., Goleen Valley, United States) designed 
to treat atrial septal defects.
CLINICAL CASES
Three patients, two females, with continuous 
murmur in the second left intercostal space, broad 
pulse, electrocardiographic and radiological data of left 
ventricular volume overload and pulmonary hyperflow 
were evaluated by echocardiography. The presence of 
patent ductus arteriosus with continuous left-to-right 
flow and left ventricular dilation was observed (Table 1).
All guardians or tutors signed the consent form 
and the patients were taken to the laboratory of he-
modynamics for percutaneous occlusion of the ductus 
arteriosus. Patients were submitted to general anesthesia, 
and arterial and femoral venipuncture; after receiving 
heparin at a dose of 100  U/kg, full hemodynamic 
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assessment was performed, which detected high pul-
monary blood pressure in the third case (49/32 mmHg, 
with a mean of 41  mmHg) and normal in the other 
two. The descending aortogram with modification of 
the lateral projection given by the caudal angulation, 
confirmed the presence of very short ductus arteriosus 
(Table 1) and pulmonary diameters >  3  mm, as well 
as planar aortic ampullas (Figure 1A and 2A). Due to 
the characteristics of the PDAs, it was decided that the 
AMPLATZER™ septal occluder would better adapt to 
the observed morphology, which is why we chose to 
use these devices, estimating a size 1 to 2 mm above 
the minimum ductus diameter.
In the first two cases, the cannulation of the ductus 
arteriosus was performed from the pulmonary artery to 
the descending aorta using a wedge pressure catheter 
(Arrow, Reading, United States), whereas in the third 
case, it was necessary to perform the cannulation from 
the aorta and create an arteriovenous loop through the 
ductus arteriosus, and, later, position a 0.035 × 260 cm 
Amplatz Super Stiff™ Guidewire that allows placing 
the 6 F-releasing system in the descending aorta. The 
selected AMPLATZER™ septal occluder was loaded 
and taken to the descending aorta under fluoroscopy, 
releasing the left disc of the device. Subsequently, the 
TABLE 1  
Clinical and hemodynamic characteristics of patients 
with window-type persistent ductus arteriosus 
Patient characteristics
Cases
1 2 3
Age, years 13 9 22
Gender Female Male Female
Weight, kg 42 34 64
Minimum ductus 
arteriosus diameter, mm
4 4 5,8
Qp/Qs 1,7 2,5 2,2
Size of prosthesis, mm 5 7 7
A B C
Figure 2 – Angiography in the right oblique view showing passage of the contrast to the pulmonary artery through the ductus arteriosus (A). Open-
ing of the left disk in the aortic ampulla (B). Control angiography in right oblique view, posterior to the implant, showing correct device position 
without residual shunt (C). 
A B C
Figure 1 – Lateral angiogram showing short ductus arteriosus, which empties into the pulmonary artery (A). Opening of the left disc in the aortic 
ampulla (B). Lateral angiography, posterior to the implant, showing the adequate position of the device without residual shunt (C).
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system was gently retracted until the disc was positioned 
in the ductus ampulla and the correct location was 
verified through the angiographic control, maintain-
ing gentle cable traction when removing the sheath, 
exposing the central waist within the ductus arteriosus 
and the right disc in pulmonary artery. As shown in 
Figures 1B and 2B, with the cable still attached to the 
device, we verified the absence of pressure gradients 
at the aortic level and in the left pulmonary artery, 
releasing the device. Lastly, the angiographic evalua-
tion showed proper positioning of the devices (Figures 
1C and 2C). Patients were discharged on the following 
day, without complications and advised to undergo 
endocarditis prophylaxis for 6 months thereafter. The 
echocardiograms performed at 1, 3, 6 and 12 months 
after the implant confirmed adequate device positioning 
with no associated obstructions.
DISCUSSION
Percutaneous occlusion of most angiographic vari-
ants of patent ductus arteriosus can be performed with 
a variety of devices, including coils with and without 
controlled release, as well as AMPLATZER™ I and II 
occluders.7-9 These may be used also to treat the most 
unusual anatomical variants.10 Unquestionably, the 
window-type PDA continues to show limitations to 
occlusion, basically when the minimum ductus diam-
eter is >  3  mm. The short extension of these defects, 
associated with a low length/diameter ratio complicates 
the stabilization of the previously mentioned occluders, 
which generates a high risk of embolization. Furthermore, 
device protrusion into the aorta or into the pulmonary 
artery can occur, causing obstruction of these structures. 
These factors are associated with high failure rate for 
the percutaneous closure of type B ductus arteriosus.11,12
In PDA closure, the use of double-disc devices 
such as AMPLATZER™ for muscular ventricular sep-
tal defect was initially described in adults with large 
ductus arteriosus and pulmonary artery hypertension.2-4 
Subsequently, Stone et al.6 described, also in adults, the 
implant of an AMPLATZER™ Septal Occluder device 
for the treatment of a large and short ductus. On the 
other hand, and almost simultaneously, Bialkowski et 
al.2 described the use of StarFlex® and CardioSEAL® 
devices as an option for closing the window-type 
PDA, reporting the successful treatment of two cases 
(a 62-year-old woman and a 17-year-old boy weighing 
72 kg). Unlike the cases described above, our patients 
had no significant pulmonary hypertension; however, 
the short length of the PDA forced us to consider using 
a device that could ensure adequate stabilization with 
total defect occlusion. Additionally, our patients were 
younger and weighed less. The advantages of using the 
AMPLATZER™ device are due to its double disc system 
with a short central waist, which ensures an adequate 
configuration to address the morphology of this PDA 
variant, resulting in an optimal occlusion without the 
risk of embolization. Additionally, the delivery and 
release system profile allows its implant in pediatric 
patients, as demonstrated by our cases. On the other 
hand, its disadvantage is its higher cost, in comparison 
with other generally used occluders.
Therefore, we conclude that in pediatric patients 
with window-type patent ductus arteriosus, the use of 
the AMPLATZER™ septal occluder can be safe and ef-
fective in the percutaneous treatment of these defects.
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